WEDBUSH SECURITIES INC - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 46 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WEDBUSH SECURITIES INC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$300
+1.0%
3,0000.0%0.01%
-6.7%
Q1 2023$297
+1.0%
3,0000.0%0.02%
-6.2%
Q4 2022$294
-100.0%
3,000
-76.9%
0.02%
-77.1%
Q3 2022$1,251,000
+0.2%
13,0000.0%0.07%
+2.9%
Q2 2022$1,248,000
+5.1%
13,0000.0%0.07%
+25.9%
Q1 2022$1,188,000
-2.9%
13,0000.0%0.05%
+1.9%
Q4 2021$1,224,000
+5.0%
13,0000.0%0.05%
-3.6%
Q3 2021$1,166,000
+0.1%
13,0000.0%0.06%0.0%
Q2 2021$1,165,000
+10.1%
13,0000.0%0.06%
-6.8%
Q1 2021$1,058,000
+5.6%
13,0000.0%0.06%
-33.0%
Q4 2020$1,002,000
+315.8%
13,000
+333.3%
0.09%
+282.6%
Q3 2020$241,000
+6.6%
3,0000.0%0.02%
+9.5%
Q2 2020$226,000
-5.8%
3,0000.0%0.02%
-27.6%
Q1 2020$240,000
-20.5%
3,0000.0%0.03%
+7.4%
Q4 2019$302,000
+17.1%
3,0000.0%0.03%
+8.0%
Q3 2019$258,000
-3.4%
3,0000.0%0.02%
-7.4%
Q2 2019$267,000
-10.1%
3,0000.0%0.03%
-15.6%
Q1 2019$297,000
+7.6%
3,0000.0%0.03%
-8.6%
Q4 2018$276,000
-8.9%
3,0000.0%0.04%
+2.9%
Q3 2018$303,000
+15.2%
3,0000.0%0.03%
+3.0%
Q2 2018$263,0003,0000.03%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q2 2018
NameSharesValueWeighting ↓
Man Investments (CH) AG 3,300,000$2,640,0002.48%
SYMPHONY ASSET MANAGEMENT LLC 14,000,000$11,200,0001.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 36,000,000$28,879,0001.14%
Opera Trading Capital 5,500,000$4,344,0000.89%
MACKAY SHIELDS LLC 17,789,000$14,221,0000.52%
ADVENT CAPITAL MANAGEMENT /DE/ 24,415,000$19,539,0000.37%
TENOR CAPITAL MANAGEMENT Co., L.P. 6,000,000$4,918,0000.37%
OAKTREE CAPITAL MANAGEMENT LP 28,415,000$22,732,0000.36%
GLG Partners LP 8,700,000$6,960,0000.33%
HIGHFIELDS CAPITAL MANAGEMENT LP 42,285,000$33,828,0000.28%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders